National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2022-01199"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-01199"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2022-01-24"
last_updated: "2022-01-24"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-01199"
document_type: "notice"
publication_date: "2022-01-24"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "87 FR 3566"
fr_volume: 87
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, TEP-1B:SBIR Contract Review, February 2, 2022, 10:00 a.m. to February 2, 2022, 4:30 p.m., National Cancer Institute at Shady Grove, Room 7W030, 9609 Medical Center Drive, Rockville, Maryland 20850, which was published in the *Federal Register* on December 08, 2021, FR Doc. 2021-26593, 86 FR 69660.

This notice is being amended to change the meeting date from February 2, 2022 to February 8, 2022. The meeting times and location will stay the same. The meeting is closed to public.

Dated: January 18, 2022.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.